US Patent Issued to NFLECTION THERAPEUTICS on Aug. 5 for "Naphthyridinone-aniline compounds for treatment of dermal disorders" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,240, issued on Aug. 5, was assigned to NFLECTION THERAPEUTICS INC. (Boston).

"Naphthyridinone-aniline compounds for treatment of dermal disorders" was invented by John Kincaid (Boston) and Matthew Duncton (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions in treating diseases or disorders in a subject where the subject is in need of an inhibitor of MEK where the compound is according to formula (I): where R1, R2, R2a, R3, R3a, R3b, and subscript n are as described herein."

Th...